OverviewSuggest Edit

HTG Molecular Diagnostics is a leading provider of molecular-based technology solutions for gene expression profiling, miRNA, siRNA and mRNA measurement for translational medicine and diagnostic applications. HTG’s product offerings have since expanded to include its HTG EdgeSeq product lines, which automate sample and targeted library preparation for next-generation sequencing. The Company's qNPA molecular technology platform is well-suited for reliably detecting small, yet important, changes in gene expression levels in a variety of sample types. 

TypePublic
Founded1997
HQTucson, AZ, US
Websitehtgmolecular.com
Employee Ratings2.4

Latest Updates

Employees (est.) (Dec 2018)107(+14%)
Job Openings3
Revenue (FY, 2020)$8.5 M(-55%)
Share Price (Jun 2021)$4.7(+2%)
Cybersecurity ratingCMore

Key People/Management at HTG Molecular Diagnostics

John L. Lubniewski

John L. Lubniewski

President and Chief Executive Officer
Shaun D. McMeans

Shaun D. McMeans

Senior Vice President of Finance, Administration, and Chief Financial Officer
Byron T. Lawson

Byron T. Lawson

Senior Vice President and Chief Commercial Officer
Ann F. Hanham

Ann F. Hanham

Chair of the Board
Show more

HTG Molecular Diagnostics Office Locations

HTG Molecular Diagnostics has an office in Tucson
Tucson, AZ, US (HQ)
3430 E Global Loop
Show all (1)

HTG Molecular Diagnostics Financials and Metrics

HTG Molecular Diagnostics Revenue

Embed Graph
View revenue for all periods
HTG Molecular Diagnostics's revenue was reported to be $8.55 m in FY, 2020
USD

Revenue (FY, 2020)

8.5m

Gross profit (FY, 2020)

4.6m

Gross profit margin (FY, 2020), %

53.3%

Net income (FY, 2020)

(20.9m)

EBIT (FY, 2020)

(19.6m)

Market capitalization (11-Jun-2021)

29.0m

Closing stock price (11-Jun-2021)

4.7

Cash (31-Dec-2020)

22.4m

EV

19.3m
HTG Molecular Diagnostics's current market capitalization is $29 m.
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

4.0m5.1m14.8m21.5m19.2m8.5m

Revenue growth, %

27%

Cost of goods sold

3.3m4.1m5.0m5.1m8.9m4.0m

Gross profit

706.1k996.8k9.8m16.4m10.3m4.6m
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

1.0m790.6k1.0m865.2k1.9m913.9k1.4m1.8m3.7m4.2m4.9m4.7m3.2m5.8m5.4m2.2m2.0m

Cost of goods sold

894.6k834.9k809.0k843.5k933.0k1.1m1.3m1.2m1.1m1.1m1.5m1.2m2.0m2.5m2.9m1.0m974.6k

Gross profit

129.7k(44.4k)201.9k21.8k962.8k(211.1k)75.9k523.9k2.6m3.0m3.5m3.5m1.2m3.3m2.5m1.2m988.7k

Gross profit Margin, %

13%(6%)20%3%51%(23%)6%30%71%73%70%74%36%57%46%54%50%
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

3.3m7.5m10.0m8.4m7.6m22.4m

Accounts Receivable

716.2k1.4m6.4m5.0m3.2m1.6m

Prepaid Expenses

443.1k568.2k633.5k1.1m

Inventories

1.2m1.3m1.3m1.5m
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(21.4m)(26.0m)(19.0m)(16.5m)(19.3m)(20.9m)

Depreciation and Amortization

662.6k1.5m1.2m1.5m1.3m1.3m

Inventories

(746.2k)(33.2k)77.2k(171.9k)(116.8k)(256.9k)

Accounts Payable

(312.3k)10.1k1.2m(150.2k)(156.0k)(23.8k)
USDQ1, 2015

Financial Leverage

-0.1 x
Show all financial metrics

HTG Molecular Diagnostics Cybersecurity Score

Cybersecurity ratingPremium dataset

C

75/100

SecurityScorecard logo

HTG Molecular Diagnostics Online and Social Media Presence

Embed Graph

HTG Molecular Diagnostics News and Updates

HTG Molecular Diagnostics Reports Preliminary First Quarter 2021 Financial Results

TUCSON, Ariz., April 05, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported certain preliminary financial results for the first quarter ended March 31, 2021.

HTG Molecular Diagnostics Announces Certain Preliminary 2020 Unaudited Financial Results

Preliminary full year 2020 unaudited revenue of $8.5 million

HTG Molecular Diagnostics to Announce Third Quarter 2020 Financial Results and Host Conference Call on Tuesday, November 10

TUCSON, Ariz., Oct. 30, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report its financial results for the third quarter ended September 30, 2020 after the market close on…

HTG Molecular Diagnostics Reports Full Year 2019 Results

Increased product and product-related services revenue over prior year, benefitting from expanded menu of profiling assays and increased number of customers adopting technology

HTG Molecular Diagnostics Receives European Patent Grant Notification for Methods for Subtyping Diffuse Large B-cell Lymphoma

TUCSON, Ariz., Jan. 28, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has received notification of validation of European patent number EP 3356554 for its methods for subtypin…

HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TUCSON, Ariz., May 24, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced that on May 22, 2019 the Compensation Committee of its Board of Directors granted inducement stock options to p…
Show more

HTG Molecular Diagnostics Frequently Asked Questions

  • When was HTG Molecular Diagnostics founded?

    HTG Molecular Diagnostics was founded in 1997.

  • Who are HTG Molecular Diagnostics key executives?

    HTG Molecular Diagnostics's key executives are John L. Lubniewski, Shaun D. McMeans and Byron T. Lawson.

  • How many employees does HTG Molecular Diagnostics have?

    HTG Molecular Diagnostics has 107 employees.

  • What is HTG Molecular Diagnostics revenue?

    Latest HTG Molecular Diagnostics annual revenue is $8.5 m.

  • What is HTG Molecular Diagnostics revenue per employee?

    Latest HTG Molecular Diagnostics revenue per employee is $79.9 k.

  • Who are HTG Molecular Diagnostics competitors?

    Competitors of HTG Molecular Diagnostics include Dante Labs, Q-State Biosciences and DermTech.

  • Where is HTG Molecular Diagnostics headquarters?

    HTG Molecular Diagnostics headquarters is located at 3430 E Global Loop, Tucson.

  • Where are HTG Molecular Diagnostics offices?

    HTG Molecular Diagnostics has an office in Tucson.

  • How many offices does HTG Molecular Diagnostics have?

    HTG Molecular Diagnostics has 1 office.